

|
Having more power and features than any other enterprise RDBMS, Microsoft® SQL Server® Replication has been lacking a clear, consice guide to installing, configuring, and troubleshooting for its users. Finally there is a complete and authoritative reference book that addresses these issues, guiding the reader to use SQL Server replication to its full potential. In more than one thousand pages, Microsoft SQL Server MVP Hilary Cotter shares his extensive knowledge and expertise in SQL Server Replication using methods that will be useful to the SQL Server novice as well as the experts.
In A Guide to SQL Server 2000 Transactional and Snapshot Replication, this highly experienced industry expert covers all you need to know to deploy replication in both Microsoft SQL Server only and heterogeneous environments. This text will help the reader master all aspects of SQL Server Transactional and Snapshot Replication through coverage of the following topics:
Installing Replication
A Step by Step Guide to the Wizards
Creating Transactional and Snapshot Publications
Creating Subscribers
Deploying Replication using Stored Procedures
Deploying Replication using SQL-DMO
Deploying Replication using the Replication ActiveX Controls
Replication Internals
Replication Troubleshooting |
About
the Author |
Involved in IT for more than 20 years as a web and database consultant in the tri-state area of NY/NJ/CT, Hilary Cotter was first recognized by Microsoft in 2001 with the Microsoft SQL Server MVP award. Hilary received his Bachelor of Applied Science degree in Mechanical Engineering from the University of Toronto, and subsequently studied both economics at the University of Calgary and Computer Science at UC Berkeley. He and his beautiful wife Miriam have five children ranging in age from 13 months to six years. Hilary Cotter has A companion volume to this text on merge replication is in the works for 2005.
Hilary has worked for Microsoft, Merrill Lynch, UBS-Paine Webber,
MetLife, VoiceStream, Tiffany & Co., Pacific Bell, Cahners,
Novartis, Petro-Canada, and Johnson and Johnson. |